Use of Prolonged-Infusion Beta-Lactam Antibiotics
Publication Date: August 24, 2023
Last Updated: September 1, 2023
Summary of Recommendations
Preclinical targets for reductions in CFU are 40%–70% fT>MIC for SI and up to 4-h EI, and 100% fT>MIC with concentrations that exceed up to four to eight times free drug over the steady-state concentration (fCss) for CI. No absolute target guarantees suppression of resistance but exceeding the MIC by four to six times may minimize resistance. (U, U)
620
Title
Use of Prolonged-Infusion Beta-Lactam Antibiotics
Authoring Organizations
Cystic Fibrosis Foundation
Infectious Diseases Society of America
Society of Critical Care Medicine
Society of Infectious Diseases Pharmacists
American College of Clinical Pharmacy